These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 12866028)

  • 1. Transfection of the genes for interleukin-12 into the K1735 melanoma and the EMT6 mammary sarcoma murine cell lines reveals distinct mechanisms of antitumor activity.
    Moran JP; Gerber SA; Martin CA; Frelinger JG; Lord EM
    Int J Cancer; 2003 Sep; 106(5):690-8. PubMed ID: 12866028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
    Chen PW; Ananthaswamy HN
    J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfection of transforming growth factor-beta producing tumor EMT6 with interleukin-2 elicits tumor rejection and tumor reactive cytotoxic T-lymphocytes.
    McAdam AJ; Felcher A; Woods ML; Pulaski BA; Hutter EK; Frelinger JG; Lord EM
    J Immunother Emphasis Tumor Immunol; 1994 Apr; 15(3):155-64. PubMed ID: 8032538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
    Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
    Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy.
    Li S; Zhang X; Xia X
    J Natl Cancer Inst; 2002 May; 94(10):762-8. PubMed ID: 12011227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of interleukin-12 transfection on proliferation of ovarian cancer SKOV3 cells in vitro and in vivo].
    Wang J; Zhang CQ; Liu J; Sui LH
    Ai Zheng; 2007 Dec; 26(12):1292-8. PubMed ID: 18076789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
    Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-1 and interleukin 12 synergistically induce effective antitumor immunity.
    Coughlin CM; Wysocka M; Kurzawa HL; Lee WM; Trinchieri G; Eck SL
    Cancer Res; 1995 Nov; 55(21):4980-7. PubMed ID: 7585539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12.
    Gee MS; Koch CJ; Evans SM; Jenkins WT; Pletcher CH; Moore JS; Koblish HK; Lee J; Lord EM; Trinchieri G; Lee WM
    Cancer Res; 1999 Oct; 59(19):4882-9. PubMed ID: 10519400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 12 gene transfer into skin distant from the tumor site elicits antimetastatic effects equivalent to local gene transfer.
    Oshikawa K; Rakhmilevich AL; Shi F; Sondel PM; Yang N; Mahvi DM
    Hum Gene Ther; 2001 Jan; 12(2):149-60. PubMed ID: 11177552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis inhibition by an oncolytic herpes virus expressing interleukin 12.
    Wong RJ; Chan MK; Yu Z; Ghossein RA; Ngai I; Adusumilli PS; Stiles BM; Shah JP; Singh B; Fong Y
    Clin Cancer Res; 2004 Jul; 10(13):4509-16. PubMed ID: 15240543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo induction of antitumor immunity and protection against tumor growth by injection of CD154-expressing tumor cells.
    Grangeon C; Cormary C; Douin-Echinard V; Favre G; Couderc B; Tilkin-Mariamé AF
    Cancer Gene Ther; 2002 Mar; 9(3):282-8. PubMed ID: 11896445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
    Gri G; Chiodoni C; Gallo E; Stoppacciaro A; Liew FY; Colombo MP
    Cancer Res; 2002 Aug; 62(15):4390-7. PubMed ID: 12154045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model.
    Imagawa Y; Satake K; Kato Y; Tahara H; Tsukuda M
    Auris Nasus Larynx; 2004 Sep; 31(3):239-45. PubMed ID: 15364358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local versus systemic interleukin-2: tumor formation by wild-type and B7-1-positive murine melanoma cells.
    Barnard AL; Farzaneh F; Gäken J; Darling D
    Cancer Gene Ther; 2000 Feb; 7(2):207-14. PubMed ID: 10770628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cells expressing anti-CD137 scFv induce a tumor-destructive environment.
    Yang Y; Yang S; Ye Z; Jaffar J; Zhou Y; Cutter E; Lieber A; Hellström I; Hellström KE
    Cancer Res; 2007 Mar; 67(5):2339-44. PubMed ID: 17332366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
    J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 2 expression by tumor cells alters both the immune response and the tumor microenvironment.
    Lee J; Fenton BM; Koch CJ; Frelinger JG; Lord EM
    Cancer Res; 1998 Apr; 58(7):1478-85. PubMed ID: 9537251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response.
    Erin N; Podnos A; Tanriover G; Duymuş Ö; Cote E; Khatri I; Gorczynski RM
    Oncogene; 2015 Jul; 34(29):3860-70. PubMed ID: 25263452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.